Sequus Pharmaceuticals: Clinical Trials

5 trials sponsored by Sequus Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 unknown. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Terminated 1, Unknown 1

Follow Sequus Pharmaceuticals: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
CAELYX, Paclitaxel HCl - Ovarian Neoplasms
Phase 3TerminatedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.2201997-05-012010-04-27
Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.
Doxorubicin hydrochloride (liposomal) - Sarcoma, Kaposi, HIV Infections
Phase 3CompletedSequus Pharmaceuticals2005-06-24
A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
Doxorubicin hydrochloride (liposomal), Bleomycin sulfate, Vincristine sulfate - Sarcoma, Kaposi, HIV Infections
Phase 3UnknownSequus Pharmaceuticals2252005-06-24
Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
Doxorubicin hydrochloride (liposomal), Bleomycin sulfate, Vincristine sulfate - Sarcoma, Kaposi, HIV Infections
Phase 3CompletedSequus Pharmaceuticals2202005-06-24
A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
Doxorubicin hydrochloride (liposomal) - Sarcoma, Kaposi, HIV Infections
Phase 3CompletedSequus Pharmaceuticals2005-06-24

Conditions studied

Acquired Immunodeficiency Syndrome (4)  ·  HIV Infections (4)  ·  Sarcoma, Kaposi (4)  ·  Ovarian Neoplasms (1)

Interventions

Doxorubicin (4)  ·  Liposomes (4)  ·  Bleomycin (2)  ·  Vincristine (2)  ·  liposomal doxorubicin (1)

Countries

United States (4)